These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2689396)

  • 41. A phase I/II study to evaluate radiation therapy and hyperthermia for deep-seated tumours: a report of RTOG 89-08.
    Myerson RJ; Scott CB; Emami B; Sapozink MD; Samulski TV
    Int J Hyperthermia; 1996; 12(4):449-59. PubMed ID: 8877470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer.
    Rietbroek RC; Bakker PJ; Schilthuis MS; Postma AJ; Zum Vörde Sive Vording PJ; Gonzalèz Gonzalèz D; Kurth KH; Bakker AJ; Veenhof CH
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):887-93. PubMed ID: 8598366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
    J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
    Hazuka MB; Crowley JJ; Bunn PA; O'Rourke M; Braun TJ; Livingston RB
    J Clin Oncol; 1994 Sep; 12(9):1814-20. PubMed ID: 8083705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
    Miller AA; Hargis JB; Lilenbaum RC; Fields SZ; Rosner GL; Schilsky RL
    J Clin Oncol; 1994 Dec; 12(12):2743-50. PubMed ID: 7527456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer.
    Haines I; Bosl G; Pfister D; Spiro R; Gerold F; Sessions R; Shah J; Strong E; Vikram B; Harrison L
    J Clin Oncol; 1987 Oct; 5(10):1594-600. PubMed ID: 2443621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation.
    Neidhart JA; Kohler W; Stidley C; Mangalik A; Plauche A; Anderson T; Quenzer RW; Rinehart JJ
    J Clin Oncol; 1990 Oct; 8(10):1728-38. PubMed ID: 2213108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperthermia and radiation therapy for inoperable or recurrent parotid carcinoma. A phase I/II study.
    Gabriele P; Amichetti M; Orecchia R; Valdagni R
    Cancer; 1995 Feb; 75(4):908-13. PubMed ID: 7842410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
    Frasci G; Comella P; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Parziale A; Comella G
    J Clin Oncol; 1997 Apr; 15(4):1409-17. PubMed ID: 9193333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies.
    Feyerabend T; Steeves R; Wiedemann GJ; Weiss C; Wagner T; Richter E; Robins HI
    Oncology; 1996; 53(3):214-20. PubMed ID: 8643224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiation therapy, cisplatin and hyperthermia in combination in management of patients with recurrent carcinomas of the head and neck with metastatic cervical lymph nodes.
    Serin M; Erkal HS; Cakmak A
    Int J Hyperthermia; 1999; 15(5):371-81. PubMed ID: 10519689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.
    Tummarello D; Graziano F; Isidori P; Santo A; Cetto G; Fedeli A; Rossi G; Cellerino R
    Cancer; 1996 Jun; 77(11):2251-7. PubMed ID: 8635092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial.
    Kapp DS; Petersen IA; Cox RS; Hahn GM; Fessenden P; Prionas SD; Lee ER; Meyer JL; Samulski TV; Bagshaw MA
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1481-95. PubMed ID: 2262371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomized trial of one versus two adjuvant hyperthermia treatments per week in patients with superficial tumours.
    Engin K; Tupchong L; Moylan DJ; Alexander GA; Waterman FM; Komarnicky L; Nerlinger RE; Leeper DB
    Int J Hyperthermia; 1993; 9(3):327-40. PubMed ID: 8515137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurotoxicity in a phase I trial of continuous infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer.
    Clamon GH; Baatz L; Hoffman HT; Hussey DH; Glascock M; McCulloch TM; Graham SM
    Head Neck; 1996; 18(3):236-41. PubMed ID: 8860764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.